Translational ophthalmology bridges research findings with clinical applications, aiming to swiftly advance innovative treatments for eye diseases. This interdisciplinary approach integrates discoveries from basic science, such as genetics and molecular biology, with clinical insights to improve patient care. By translating bench-side research into practical therapies, translational ophthalmology addresses pressing issues like age-related macular degeneration, glaucoma, and diabetic retinopathy. Techniques such as gene therapy, stem cell transplantation, and advanced imaging play pivotal roles in this field, offering new hope for preserving vision and enhancing quality of life. Moreover, collaborations between scientists, clinicians, and industry partners are essential for expediting the development and implementation of these cutting-edge treatments. As translational ophthalmology continues to evolve, its impact on managing and potentially curing sight-threatening conditions remains profound.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom